慢性再障，起病缓慢，以贫血为主要临床表现，出血多限于皮肤黏膜，且不严重，可并发感染，但常以呼吸道为主，容易控制。病程多在4年以上，甚至可长达10年之久。若治疗得当，坚持不懈，大多可治愈，但也有病人迁延多年不愈。少数病人可急性发作，病情急转直下，常与感染有关。
阳虚型和肾阴虚型总有效率分别为97.2和61.2，急性再障（acute aplastic anemia AAA）和慢性再障（chronic aplastic anemia CAA）的总有效率分别为65.3和91.7，肾阳虚型AAA和CAA的有效率分别为100和96.4，肾阴虚型AAA和CAA的有效率分别为57.5和75，表明肾...
基于18个网页-相关网页
慢性再生障碍性贫血 chronic aplastic anemia ; CAA ; aplastic anemia ; Chronic
与慢性再生障碍性贫血 Chronic aplastic anemia
在慢性再生障碍性贫血 chronic aplastic anemia
例慢性再生障碍性贫血 chronic aplastic anemia
探讨慢性再生障碍性贫 Clinic Aplastic Anemia
Methods:120 cases of chronic aplastic anemia were randomly divided into two groups,90 cases treated with herbs(24 cases of kidney-Yang deficiency 37 cases of kidney- Yin deficiency 29 cases of kidney-Yin and Yang deficiency),and 30 cases treated with chemical.
方法: 将120例慢性再障患者随机分为中药组90例(其中肾阳虚组24例、肾阴虚组37例、肾阴阳两虚组29例),西药组30例。
参考来源 - 补肾益髓法对慢性再生障碍性贫血造血细胞调控因子作用的研究·2,447,543篇论文数据，部分数据来源于NoteExpress
根据临床特征分为急性再障和慢性再障。
Clinically it can be divided into two kinds, that is acute aplastic anemia and chronic aplastic anemia.
造血干细胞移植是治愈重型再障的主要手段，同基因造血干细胞移植也适合慢性再障。
Severe aplastic anemia can be cured by haematopoietic stem cell transplantation. Synegenic HSCT is the best choice for severe aplastic anemia and chronic aplastic anemia.
目的：观察补肾方对慢性再障患者造血调控因子的调节作用，探讨补肾中药的调节机制。
Objective: to observe how Bushen formula to regulate hematopoiesis regulation factors of chronic aplastic anemia patients, and discuss the regulation mechanism of kidney promote herbs.
应用推荐